0001493152-20-007488.txt : 20200430
0001493152-20-007488.hdr.sgml : 20200430
20200430200835
ACCESSION NUMBER: 0001493152-20-007488
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200428
FILED AS OF DATE: 20200430
DATE AS OF CHANGE: 20200430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Mitchell S
CENTRAL INDEX KEY: 0001383492
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 20837902
MAIL ADDRESS:
STREET 1: ONE FERRY BUILDING, SUITE 255
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
4/A
1
ownership.xml
X0306
4/A
2020-04-28
2020-04-30
0
0001642380
OncoCyte Corp
OCX
0001383492
Levine Mitchell S
15 CUSHING
IRVINE
CA
92618
0
1
0
0
Chief Financial Officer
Restricted Stock Units
2020-04-28
4
A
0
20000
0
A
Common Stock
20000
20000
D
Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock.
The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant.
/s/ Mitchell S. Levine
2020-04-30